![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SUCO |
Gene summary for SUCO |
![]() |
Gene information | Species | Human | Gene symbol | SUCO | Gene ID | 51430 |
Gene name | SUN domain containing ossification factor | |
Gene Alias | C1orf9 | |
Cytomap | 1q24.3 | |
Gene Type | protein-coding | GO ID | GO:0001503 | UniProtAcc | B4DYM4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51430 | SUCO | CCI_1 | Human | Cervix | CC | 7.31e-03 | 6.60e-01 | 0.528 |
51430 | SUCO | CCI_3 | Human | Cervix | CC | 3.51e-02 | 5.68e-01 | 0.516 |
51430 | SUCO | LZE4T | Human | Esophagus | ESCC | 5.24e-10 | 4.11e-01 | 0.0811 |
51430 | SUCO | LZE7T | Human | Esophagus | ESCC | 8.32e-11 | 7.76e-01 | 0.0667 |
51430 | SUCO | LZE8T | Human | Esophagus | ESCC | 6.01e-05 | 1.29e-01 | 0.067 |
51430 | SUCO | LZE20T | Human | Esophagus | ESCC | 2.79e-04 | 1.15e-01 | 0.0662 |
51430 | SUCO | LZE22T | Human | Esophagus | ESCC | 4.05e-06 | 3.37e-01 | 0.068 |
51430 | SUCO | LZE24T | Human | Esophagus | ESCC | 2.72e-18 | 4.08e-01 | 0.0596 |
51430 | SUCO | LZE21T | Human | Esophagus | ESCC | 8.09e-04 | 4.25e-01 | 0.0655 |
51430 | SUCO | P1T-E | Human | Esophagus | ESCC | 2.83e-10 | 6.07e-01 | 0.0875 |
51430 | SUCO | P2T-E | Human | Esophagus | ESCC | 2.02e-48 | 9.99e-01 | 0.1177 |
51430 | SUCO | P4T-E | Human | Esophagus | ESCC | 2.80e-27 | 7.04e-01 | 0.1323 |
51430 | SUCO | P5T-E | Human | Esophagus | ESCC | 1.68e-16 | 4.54e-01 | 0.1327 |
51430 | SUCO | P8T-E | Human | Esophagus | ESCC | 1.92e-22 | 3.17e-01 | 0.0889 |
51430 | SUCO | P9T-E | Human | Esophagus | ESCC | 1.18e-15 | 3.59e-01 | 0.1131 |
51430 | SUCO | P10T-E | Human | Esophagus | ESCC | 3.35e-20 | 4.18e-01 | 0.116 |
51430 | SUCO | P11T-E | Human | Esophagus | ESCC | 1.05e-12 | 7.71e-01 | 0.1426 |
51430 | SUCO | P12T-E | Human | Esophagus | ESCC | 5.46e-17 | 3.21e-01 | 0.1122 |
51430 | SUCO | P15T-E | Human | Esophagus | ESCC | 1.42e-34 | 7.01e-01 | 0.1149 |
51430 | SUCO | P16T-E | Human | Esophagus | ESCC | 2.70e-45 | 7.79e-01 | 0.1153 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00016497 | Cervix | CC | osteoblast differentiation | 47/2311 | 229/18723 | 2.88e-04 | 3.11e-03 | 47 |
GO:0045667 | Cervix | CC | regulation of osteoblast differentiation | 29/2311 | 132/18723 | 1.32e-03 | 1.05e-02 | 29 |
GO:00015037 | Cervix | CC | ossification | 71/2311 | 408/18723 | 1.67e-03 | 1.28e-02 | 71 |
GO:00487712 | Cervix | CC | tissue remodeling | 34/2311 | 175/18723 | 4.68e-03 | 2.82e-02 | 34 |
GO:0045669 | Cervix | CC | positive regulation of osteoblast differentiation | 16/2311 | 69/18723 | 8.75e-03 | 4.48e-02 | 16 |
GO:000164918 | Esophagus | ESCC | osteoblast differentiation | 140/8552 | 229/18723 | 1.63e-06 | 1.95e-05 | 140 |
GO:000150317 | Esophagus | ESCC | ossification | 232/8552 | 408/18723 | 3.00e-06 | 3.40e-05 | 232 |
GO:00456675 | Esophagus | ESCC | regulation of osteoblast differentiation | 77/8552 | 132/18723 | 2.28e-03 | 1.00e-02 | 77 |
GO:00329631 | Esophagus | ESCC | collagen metabolic process | 62/8552 | 104/18723 | 2.90e-03 | 1.22e-02 | 62 |
GO:00456695 | Esophagus | ESCC | positive regulation of osteoblast differentiation | 43/8552 | 69/18723 | 3.93e-03 | 1.59e-02 | 43 |
GO:000164911 | Liver | HCC | osteoblast differentiation | 115/7958 | 229/18723 | 1.08e-02 | 3.99e-02 | 115 |
GO:000150310 | Oral cavity | OSCC | ossification | 203/7305 | 408/18723 | 5.54e-06 | 6.19e-05 | 203 |
GO:000164910 | Oral cavity | OSCC | osteoblast differentiation | 118/7305 | 229/18723 | 7.51e-05 | 5.85e-04 | 118 |
GO:0032963 | Oral cavity | OSCC | collagen metabolic process | 54/7305 | 104/18723 | 5.00e-03 | 1.96e-02 | 54 |
GO:00487713 | Oral cavity | OSCC | tissue remodeling | 84/7305 | 175/18723 | 9.39e-03 | 3.36e-02 | 84 |
GO:00456674 | Oral cavity | OSCC | regulation of osteoblast differentiation | 65/7305 | 132/18723 | 1.06e-02 | 3.60e-02 | 65 |
GO:000150322 | Oral cavity | EOLP | ossification | 70/2218 | 408/18723 | 8.89e-04 | 6.81e-03 | 70 |
GO:000164922 | Oral cavity | EOLP | osteoblast differentiation | 41/2218 | 229/18723 | 4.47e-03 | 2.42e-02 | 41 |
GO:0032964 | Oral cavity | EOLP | collagen biosynthetic process | 13/2218 | 51/18723 | 5.43e-03 | 2.82e-02 | 13 |
GO:0010712 | Oral cavity | EOLP | regulation of collagen metabolic process | 12/2218 | 47/18723 | 7.31e-03 | 3.54e-02 | 12 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SUCO | SNV | Missense_Mutation | c.2202N>C | p.Glu734Asp | p.E734D | Q9UBS9 | protein_coding | tolerated(0.1) | benign(0.137) | TCGA-DD-A1EB-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
SUCO | SNV | Missense_Mutation | c.3581A>T | p.Tyr1194Phe | p.Y1194F | Q9UBS9 | protein_coding | tolerated(0.29) | benign(0.009) | TCGA-DD-A4NA-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
SUCO | SNV | Missense_Mutation | novel | c.2986N>T | p.Ile996Leu | p.I996L | Q9UBS9 | protein_coding | tolerated(0.14) | benign(0) | TCGA-DD-AACI-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
SUCO | SNV | Missense_Mutation | c.1456N>T | p.Ser486Cys | p.S486C | Q9UBS9 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-44-7670-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | docetaxel | SD | |
SUCO | SNV | Missense_Mutation | c.4170N>T | p.Glu1390Asp | p.E1390D | Q9UBS9 | protein_coding | tolerated_low_confidence(0.17) | benign(0.056) | TCGA-44-7670-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | docetaxel | SD | |
SUCO | SNV | Missense_Mutation | c.3969N>C | p.Gln1323His | p.Q1323H | Q9UBS9 | protein_coding | tolerated_low_confidence(0.1) | benign(0.28) | TCGA-44-7671-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
SUCO | SNV | Missense_Mutation | c.3583N>G | p.Ile1195Val | p.I1195V | Q9UBS9 | protein_coding | tolerated(0.18) | benign(0.107) | TCGA-44-8117-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
SUCO | SNV | Missense_Mutation | novel | c.2686N>T | p.Pro896Ser | p.P896S | Q9UBS9 | protein_coding | tolerated_low_confidence(1) | benign(0.003) | TCGA-50-6590-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Chemotherapy | paclitaxel | CR |
SUCO | SNV | Missense_Mutation | novel | c.4147N>C | p.Asp1383His | p.D1383H | Q9UBS9 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.986) | TCGA-55-6982-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Chemotherapy | gemzar | PD |
SUCO | SNV | Missense_Mutation | c.260N>T | p.Arg87Leu | p.R87L | Q9UBS9 | protein_coding | deleterious_low_confidence(0.01) | benign(0.007) | TCGA-55-8087-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |